Literature DB >> 31531414

Assessment of national tuberculosis and HIV collaborative program implementation status in health care settings of Ethiopia.

Wudinesh Belete1, Minilik Demissie1, Atsbeha Gebreegziabher1, Desta Kassa1, Gebremedine Gebre-Michael1, Getnet Mesfin1, Abebaw Kebede1, Andargachew Kumsa2, Lelissa Fekadu2, Biruk Kebede2, Fekadeselassie Mikru3, Kassa Hailu3, Addisalem Yilma3, Eshetu Kebede4, Ismael Hassen3, Abera Bekele3, Getachew Wondimagegne5, Kumlachew Abate6, Daniel Fiseha5, Ezra Shimeles5, Yibeltal Assefa1.   

Abstract

BACKGROUND: Ethiopia has adopted the World Health Organization recommendation for TB and HIV collaborative activities since 2004. These collaborative activities have been scaled up in a phased manner and covered large number of health facilities across the nation. However, there is scarcity of information on implementation of these collaborative activities in Ethiopia.
OBJECTIVE: To assess the status of implementation of TB and HIV collaborative activities in health facility settings of Ethiopia.
METHODS: A cross sectional study mainly quantitative supplemented by qualitative methods was undertaken from May 10 to July 10, 2014 in 132 selected health facilities. Statistical analysis was performed using SPSS version 20. RESULT: About 81% of the respondents in the selected health facilities reported the screening of People Living with HIV in care for TB at every follow up visit, whereas, only 28.7% of those health facilities reported the screening of PLWHIV for TB at enrolment to HIV chronic care. About half of the public health facilities assessed were not implementing Isoniazid Preventive Therapy and only 18.2% of eligible clients were getting this Preventive Therapy. Among the co-infected patients, 32% were not linked to chronic care services and 45.3% were not getting ART during TB treatment. On the other hand, about two thirds of the co-infected patients are getting the Cotrimoxazole Prophylaxis Therapy.
CONCLUSION: Most of anti-TB and HIV collaborative activities were not implemented as expected in the health facilities. Thus it needs integration from the ministry to the health facilities level in order to improve the collaborative activities.

Entities:  

Keywords:  Cotrimexazole Prophylaxis Therapy; Ionized Prophylaxis Therapy; Tuberculosis screening; people living with HIV

Year:  2017        PMID: 31531414      PMCID: PMC6748620     

Source DB:  PubMed          Journal:  Ethiop J Public Health Nutr        ISSN: 2523-1170


  16 in total

1.  Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions.

Authors:  Haileyesus Getahun; Reuben Granich; Delphine Sculier; Christian Gunneberg; Leopold Blanc; Paul Nunn; Mario Raviglione
Journal:  AIDS       Date:  2010-11       Impact factor: 4.177

2.  Antiretroviral treatment uptake and attrition among HIV-positive patients with tuberculosis in Kibera, Kenya.

Authors:  K Tayler-Smith; R Zachariah; M Manzi; W Kizito; A Vandenbulcke; J Sitienei; J Chakaya; A D Harries
Journal:  Trop Med Int Health       Date:  2011-08-11       Impact factor: 2.622

3.  Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, Ethiopia.

Authors:  Amenu Wesen; Getnet Mitike
Journal:  BMC Int Health Hum Rights       Date:  2012-03-27

4.  Assessing the accessibility of HIV care packages among tuberculosis patients in the Northwest Region, Cameroon.

Authors:  Nwarbébé Barnabas Njozing; San Sebastian Miguel; Pius Muffih Tih; Anna-Karin Hurtig
Journal:  BMC Public Health       Date:  2010-03-12       Impact factor: 3.295

5.  Clinical management of tuberculosis and HIV-1 co-infection.

Authors:  C Schutz; G Meintjes; F Almajid; R J Wilkinson; A Pozniak
Journal:  Eur Respir J       Date:  2010-10-14       Impact factor: 16.671

6.  Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.

Authors:  Dominique J Pepper; Suzaan Marais; Robert J Wilkinson; Feriyl Bhaijee; Virginia De Azevedo; Graeme Meintjes
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

7.  Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain.

Authors:  Asuncion Diaz; Mercedes Diez; Maria Jose Bleda; Mikel Aldamiz; Miguel Camafort; Xabier Camino; Concepcion Cepeda; Asuncion Costa; Oscar Ferrero; Paloma Geijo; Jose Antonio Iribarren; Santiago Moreno; Maria Elena Moreno; Pablo Labarga; Javier Pinilla; Joseba Portu; Federico Pulido; Carmen Rosa; Juan Miguel Santamaría; Mauricio Telenti; Luis Trapiella; Monica Trastoy; Pompeyo Viciana
Journal:  BMC Infect Dis       Date:  2010-09-14       Impact factor: 3.090

Review 8.  Improving the prevention, diagnosis and treatment of TB among people living with HIV: the role of operational research.

Authors:  Delphine Sculier; Haileyesus Getahun; Christian Lienhardt
Journal:  J Int AIDS Soc       Date:  2011-07-06       Impact factor: 5.396

9.  Evaluation of collaborative TB/HIV activities in a general hospital in Addis Ababa, Ethiopia.

Authors:  Aragie Kassa; Degu Jerene; Yibeltal Assefa; Azmera Teka; Abraham Aseffa; Amare Deribew
Journal:  BMC Res Notes       Date:  2012-01-26

10.  Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial.

Authors:  Andrew J Nunn; Peter Mwaba; Chifumbe Chintu; Alwyn Mwinga; Janet H Darbyshire; Alimuddin Zumla
Journal:  BMJ       Date:  2008-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.